Skip to main content
Atrás
Watch Compare

INTENSITY THERAPEUTICS, INC.

Calidad de datos: 83%
INTS
Nasdaq Manufacturing Chemicals
$5.57
▲ $0.07 (1.25%)
Cap. Mercado: 14.15 M
Precio
$5.57
Cap. Mercado
14.15 M
Rango del Día
$5.51 — $5.75
Rango de 52 Semanas
$4.63 — $50.00
Volumen
8,711
Apertura $5.63
Promedio 50D / 200D
$7.43
25.08% below
Promedio 50D / 200D
$8.41
33.78% below

Quick Summary

Puntos Clave

Negative free cash flow of -9.23 M

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-246.78%
Below sector avg (-51.02%)
ROIC-197.29%
Net MarginN/A
Op. MarginN/A

Seguridad

Debt / Equity
N/A
Current Ratio3.60
Interest CoverageN/A

Valoración

PE (TTM)
-1.22
Above sector avg (-1.98)
P/B Ratio1.96
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (44 pares)
Métrica Acción Mediana del Sector
P/E -1.2 -2.0
P/B 2.0 5.1
ROE % -246.8 -51.0
Net Margin % — -150.2
Rev Growth 5Y % — 9.3
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -11.61 M
ROE -246.78% ROA -165.47%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -9.23 M
ROIC -197.29% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 3.60
Interest Coverage N/A Asset Turnover N/A
Working Capital 5.91 M Tangible Book Value 7.22 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1.22 Forward P/E N/A
P/B Ratio 1.96 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -65.26%
Market Cap 14.15 M Enterprise Value 7.08 M
Per Share
EPS (Diluted TTM) -8.56 Revenue / Share N/A
FCF / Share -3.63 OCF / Share -3.63
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 79.55%
SBC-Adj. FCF -11.27 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023
Revenue — — —
Net Income -11.61 M -16.27 M -10.54 M
EPS (Diluted) -8.56 -1.17 -1.38
Gross Profit — — —
Operating Income -11.97 M -16.59 M -8.32 M
EBITDA — — —
R&D Expenses 6.79 M 10.50 M 4.79 M
SG&A Expenses — — —
D&A — — —
Interest Expense — 0.0 305,000.0
Income Tax 0.0 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023
Total Assets 14.10 M 4.78 M 17.30 M
Total Liabilities 2.23 M 1.87 M 4.13 M
Shareholders' Equity 11.88 M 2.92 M 13.16 M
Total Debt — — —
Cash & Equivalents 11.92 M 2.59 M 8.56 M
Current Assets 12.71 M 3.36 M 15.46 M
Current Liabilities 2.15 M 1.76 M 3.96 M